東光化工(01702.HK)年度溢利減少約55.5%至約8640萬元
格隆匯3月26日丨東光化工(01702.HK)公吿,截至2024年12月31日止年度,集團的溢利錄得大幅減少,由上年度的約人民幣194.1百萬元減少約人民幣107.7百萬元或55.5%至報吿期間的約人民幣86.4百萬元,主要由於整體毛利及毛利率減少。集團的收入由上年度約人民幣2,920.7百萬元減少約人民幣345.3百萬元或11.8%至報吿期間的約人民幣2,575.4百萬元。董事會建議就截至2024年12月31日止年度派付末期股息每股普通股3.6港仙(2023年:8港仙)。
於報吿期間,集團尿素產品的平均售價為約每噸人民幣1,842元,較截至2023年12月31日止年度的約每噸人民幣2,189元減少約15.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.